Search research articles
Contact Us
Filters
Showing results (61-70 of 98) with videos related to
Page
of 10
Sort By:
Diabetes, Obesity & Metabolism
|
May 18, 2022
Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies
Tamam Abdul-Ghani, Curtiss Puckett, Osama Migahid, et al.
Diabetes/Metabolism Research and Reviews
|
April 12, 2019
Exenatide modulates visual cortex responses
Paola Binda, Roy Eldor, Claudia Huerta, et al.
Diabetes Care
|
March 1, 2023
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Siham Abdelgani, Ahmed Khattab, John Adams, et al.
Diabetes, Obesity & Metabolism
|
March 7, 2022
Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance
J David Spence, Catherine Viscoli, Walter N Kernan, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association
|
May 13, 2022
A randomised crossover trial: Exploring the dose-response effect of carbohydrate restriction on glycaemia in people with well-controlled type 2 diabetes
Ebaa Al-Ozairi, Al Awadi Reem, Abeer El Samad, et al.
Diabetes Care
|
May 16, 2025
One-Hour Plasma Glucose Predicts the Progression From Normal Glucose Tolerance to Prediabetes
Muhammad Abdul-Ghani, Mohamed Abu-Farha, Tamam Abdul-Ghani, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 7, 2014
Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range
Diedre Winner, Luke Norton, Mustafa Kanat, et al.
Endocrinology, Diabetes & Metabolism
|
March 1, 2019
Impaired left ventricular diastolic function in T2DM patients is closely related to glycemic control
Geoffrey D Clarke, Marjorie Molina-Wilkins, Carolina Solis-Herrera, et al.
Diabetes Care
|
August 5, 2016
Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects
Roy Eldor, Giuseppe Daniele, Claudia Huerta, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2015
Dapagliflozin lowers plasma glucose concentration and improves β-cell function
Aurora Merovci, Andrea Mari, Carolina Solis-Herrera, et al.
Page
of 10
Search research articles
Search
Showing results (61-70 of 98) with videos related to
Sort By:
Page
of 10
Diabetes, Obesity & Metabolism
|
May 18, 2022
Type 2 diabetes subgroups and response to glucose-lowering therapy: Results from the EDICT and Qatar studies
Tamam Abdul-Ghani, Curtiss Puckett, Osama Migahid, et al.
Diabetes/Metabolism Research and Reviews
|
April 12, 2019
Exenatide modulates visual cortex responses
Paola Binda, Roy Eldor, Claudia Huerta, et al.
Diabetes Care
|
March 1, 2023
Distinct Mechanisms Responsible for the Increase in Glucose Production and Ketone Formation Caused by Empagliflozin in T2DM Patients
Siham Abdelgani, Ahmed Khattab, John Adams, et al.
Diabetes, Obesity & Metabolism
|
March 7, 2022
Efficacy of lower doses of pioglitazone after stroke or transient ischaemic attack in patients with insulin resistance
J David Spence, Catherine Viscoli, Walter N Kernan, et al.
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association
|
May 13, 2022
A randomised crossover trial: Exploring the dose-response effect of carbohydrate restriction on glycaemia in people with well-controlled type 2 diabetes
Ebaa Al-Ozairi, Al Awadi Reem, Abeer El Samad, et al.
Diabetes Care
|
May 16, 2025
One-Hour Plasma Glucose Predicts the Progression From Normal Glucose Tolerance to Prediabetes
Muhammad Abdul-Ghani, Mohamed Abu-Farha, Tamam Abdul-Ghani, et al.
The Journal of Clinical Endocrinology and Metabolism
|
May 7, 2014
Strong association between insulin-mediated glucose uptake and the 2-hour, not the fasting plasma glucose concentration, in the normal glucose tolerance range
Diedre Winner, Luke Norton, Mustafa Kanat, et al.
Endocrinology, Diabetes & Metabolism
|
March 1, 2019
Impaired left ventricular diastolic function in T2DM patients is closely related to glycemic control
Geoffrey D Clarke, Marjorie Molina-Wilkins, Carolina Solis-Herrera, et al.
Diabetes Care
|
August 5, 2016
Discordance Between Central (Brain) and Pancreatic Action of Exenatide in Lean and Obese Subjects
Roy Eldor, Giuseppe Daniele, Claudia Huerta, et al.
The Journal of Clinical Endocrinology and Metabolism
|
February 25, 2015
Dapagliflozin lowers plasma glucose concentration and improves β-cell function
Aurora Merovci, Andrea Mari, Carolina Solis-Herrera, et al.
Page
of 10